DOCSLIB.ORG

Candida Albicans, 152 Ascaris Lumbricoides, 172 Borrelia

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Candida Albicans, 152 Ascaris Lumbricoides, 172 Borrelia Index AIDS, 117 Arteritis C-s (Chiirg-Strauss) syndrome, CDC surveillance case giant cell (GCA), 218-219 213-214 definition for, 119 temporal,218-219 Candida albicans, 152 ocular manifestations of Arthritis Candidiasis, 152-153 infection with, 117-125 psoriatic, 207-208 Cataract surgery, 81-83 retinal manifestations of, rheumatoid, see Rheumatoid CDC surveillance case 119 arthritis definition for AIDS, 119 AKC (atopic keratoconjunc- AS (ankylosing spondylitis), Cell tivitis),188-189 198-200 aqueous, 19 Alkylating drugs, 72-73 Ascariasis, 172 defined,3-4 Amoebiasis, 162-163 Ascaris lumbricoides, 172 Chest radiograph, 50 Anaerobic endophthalmitis, Atopic keratoconjunctivitis Chorioretinitis, defined, 4 chronic, 269-270 (AKC), 188-189 Chorioretinopathy, ANCA autoantibodies, 49-50 Autoimmune uveitis, serpiginous, 248-249 Angle signs, 22-23 experimental (EAU), 241 Choroid disorders, 247-252 Animals causing uveitis, 182- Azathioprine, 73 Choroidal signs, 29 183 Choroiditis, 29 Ankylosing spondylitis (AS), defined,4 198-200 Bacterial diseases causing multifocal, and panuveitis Anterior chamber signs, 19- uveitis, 134-144 (MCP) syndrome, 247-248 20 Bacterial endophthalmitis, punctate inner (PIC), 248 Anterior uveitis, 9 infectious, 267-269 vitiliginous, 240 Antiphospholipid antibodies Band keratopathy, 17, 19 Chiirg-Strauss (C-S) (APLA),49 BARN (bilateral acute retinal syndrome,213-214 APMPPE (acute posterior necrosis syndrome), 115- Cicatricial pemphigoid (CP), multifocal placoid 117 191-193 pigment epitheliopathy), Beh-;et's disease, 200-202 Ciliary body disorders, 229- 236-239 Biographical information, 32 233 Aqueous cell and flare, 19 Birdshot retinochoroiditis, Ciliary body signs, 20-22 Aqueous convection currents, 240-243 CJD (Creutzfeldt-Jakob 20 Blood tests, special, 49-50 disease),114-115 ARN, see Retinal necrosis Borrelia burgdorferi, 137- CME (cystoid macular edema), syndrome, acute 138 27,64-65 ARPE (acute retinal pigment Bowel disease, inflammatory, CMV (cytomegalovirus) epitheliitis), 239-240 (IBD), 204-205 retinitis, 119, 123-125 Arteriolar attenuation, 27 Brucella species, 142 Coccidioides, 153 Arteriolitis, retinal, see Retinal Brucellosis, 142-143 Coccidiomycosis, 153-154 arteriolitis Busacca nodules, 21 Cogan's syndrome, 214 273 274 Index Colitis, ulcerative, 204-205 DM-PM (dermatomyositis and Hay fever, 187-188 Collagen fibers, 197 polymyositis),202-203 Heerfordt's syndrome, 254 Collagen vascular diseases, DUSN (diffuse unilateral Helminthic diseases causing 197 subacute neuroretinitis), uveitis, 170-177 with ocular involvement, 176-177 Hemorrhagic conjunctivitis 198 syndrome, acute (AHC), Conjunctival biopsy, 53-54, 56 105 Conjunctival disorders, 229 EAU (experimental auto­ Herpes B virus (HV-B), 100- Conjunctival nodules, 14, 17 immune uveitis), 241 103 Conjunctival signs, 14-16 EBV (Epstein-Barr virus), 103- Herpes simplex virus (HSV), Contact dermatitis of eyelids, 105 97-98 228-229 EM (erythema multiforme), Heterochromia iridium, 22 Corneal signs, 16-19 203-204 Heterochromic iridocyclitis, Corneal surgery, 80-81 Endophthalmitis Fuchs' (FHI), 231-233 Corticosteroids anaerobic, chronic, 269- Histoplasma capsulatum, 149 oral, 69-71 270 Histoplasmosis syndrome, relative potencies of, 70 infectious, 267-269 ocular (OHS), 149-152 topical,62-65 Epstein-Barr virus (EBV), 103- History of present illness Coxsackievirus, 105-106 105 (HOPI),32 CP (cicatricial pemphigoid), Erythema multiforme (EM), HIV, 117-118 191-193 203-204 ocular manifestations of CREST syndrome, 215 Eye, 3 infection with, 117-125 Creutzfeldt-Jakob disease red,14 HLA (human leukocyte (CJD),114-115 Eyelids, contact dermatitis of, antigen) typing, 4-5, 50 Crohn's disease, 204-205 228-229 HOPI (history of present Cryptococcosis, 155-156 illness), 32 Cryptococcus neoformans, 155 HSV (herpes simplex virus), Cyclitis, defined, 4 FHI (Fuchs' heterochromic 97-98 Cyclophosphamide, 72-73 iridocyclitis), 231-233 Human leukocyte antigen Cycloplegia, 61-62 Flare (HLA) typing, 4-5, 50 Cyclosporin,73-74 aqueous, 19 HV-B (herpes B virus), 100- Cysticercosis, 174-176 defined,4 103 Cystoid macular edema Fluorescein angiography, 52- Hydrocortisone, 63 (CME), 27, 64-65 53 Hypopyon Cytomegalovirus (CMV) Folic acid analogs, 73 defined, 4 retinitis, 119, 123-125 Fuchs' heterochromic double, 20 Cytotoxic immunosuppressive iridocyclitis (FHI), 231- Hypotheses agents, 71-74 233 listing of, 39-40 Fundus, white dot syndromes selection among, 40, 43 of,237-247 Dalen-Fuchs nodules, 205, 251 Fungal diseases causing DBDS (differential-based uveitis, 149-156 IBD (inflammatory bowel diagnostic system), 31-43 disease), 204-205 Dermatitis, contact, of eyelids, Immune complex (IC) 228-229 Giant cell arteritis (GCA), 218- formation, 8, 9 Dermatomyositis and 219 Immunologic diseases, ocular polymyositis (DM-PM), Giardia lamblia, 164 inflammation associated 202-203 Giardiasis, 164-165 with, 7-9, 187-255 Dexamethasone, 63 Glaucoma, secondary, 23 type I hypersensitivity, 7, 8, Diagnosis Glaucoma surgery, 81 187-190 methods of, in uveitis, 31-43 Granulomatosis, Wegener's type II hypersensitivity, 7-9, process of making, 31 219-220 191-195 Differential-based diagnostic Granulomatous precipitates, type III hypersensitivity, 8, system (DBDS), 31-43 5-6 9, 197-221 Index 275 type IV hypersensitivity, 8, distribution, 18 Medical history, past (PMH), 9,228-255 old,19 33 Immunosuppressive agents response to therapy, 18 Medical therapy for uveitis, cytotoxic,71-74 Keratoconjunctivitis 58-74 specific, 72-74 atopic (AKC), 188-189 general treatment strategies, Infectious diseases, ocular vemal(VKC),189-190 59 inflammation associated Keratouveitis, viral diseases nonspecific, 59-60 with, 7, 97-183 associated with, 97-100 regional, 65-67 bacterial,134-144 Koeppe nodules, 21 specific, 60-74 fungal, 149-156 Koplik's spots, 112 systemic,67-74 helminthic,170-177 KP (keratic precipitates), see topical, 61-65 by insects, 180-181 Keratic precipitates Methotrexate, 73 protozoal, 159-166 Krill's disease, 239 MEWDS (multiple evanescent viral, 97-125 white dot sydrome), 244- Infectious endophthalmitis, 245 267-269 Laboratory evaluation, 55 Mumps virus (MV), 111-112 Inflammation, postoperative, Laboratory testing Mycobacterium leprae, 141-142 91-93 radiologic, 50-52 Mycobacterium tuberculi, 139 Inflammatory precipitates, 5-6 for uveitis, 45-56 Mydriasis, 61-62 Influenza A, 109-110 Leber's idiopathic stellate Insects causing uveitis, 180- neuroretinitis (USN), 243- 181 244 "Name-meshing" system of Intermediate uveitis, 9 Lens-induced uveitis, 193- diagnosis, 31 Interstitial retinoid binding 195 Neuroretinitis protein (IRBP), 241 Lenticular signs, 23-24 diffuse unilateral subacute Intraocular inflammation, see Leprosy, 141-142 (DUSN),176-177 Ocular inflammation Leptospira species, 138 stellate, Leber's idiopathic Intraocular lens implantation, Leptospirosis, 138-139 (USN), 243-244 83 USN (Leber's idiopathic Non-Hodgkin's lymphoma of Intraocular lymphoma, 265- stellate neuroretinitis), CNS (NHL-CNS), 265-266 267 243-244 Nongranulomatous IRBP (interstitial retinoid Los loa, 174 precipitates, 5 binding protein), 241 Loiasis, 174 Nonsteroidal anti­ Iridocyclitis Lupus erythematosus, inflammatory drugs defined,4 systemic (SLE), 216-218 (NSAIDs), oral, 67-69 Fuchs' heterochromic (FHI), Lyme disease, 137-138 231-233 Lymphoma, intraocular, 265- idiopathic, 229-231 267 Ocular cicatricial pemphigoid Iris atrophy, sector, 22 (OCP),191-192 Iris disorders, 229-233 Ocular examination, 38-39 Iris heterochromia, 22 Masquerade syndromes, Ocular histoplasmosis Iris signs, 20-22 ocular syndrome (OHS), 149-152 Iritis, defined, 4 inflammation associated Ocular history, past (POH), Ixodes ticks, 137 with,265-270 32-33 chronic anaerobic Ocular inflammation, 3 endophthalmitis, 269-270 associated with JRA (juvenile rheumatoid infectious endophthalmitis, immunologic diseases, see arthritis), 205-207 267-269 Immunologic diseases, intraocular lymphoma, 265- ocular inflammation 267 associated with Keratic precipitates (KP), 16- MCP (multifocal choroiditis associated with infectious 19 and panuveitis) syndrome, diseases, see Infectious appearance, 17 247-248 diseases, ocular inflam­ defined, 4 Measles virus, 112-113 mation associated with 276 Index Ocular inflammation (cont.) Periphlebitis, retinal, 26 Reticulum cell sarcoma (RCS), associated with masquerade Phlyctenulosis, 229 265-267 syndromes, see Physical examination, general, Retinal arteriolitis, 26 Masquerade syndromes, 33 venulitis versus, 27 ocular inflammation PIC (punctate inner Retinal detachment, exudative, associated with choroiditis),248 29 associated with trauma, see Placoidpigment Retinal disorders, 237-247 Traumatic uveitis epitheliopathy, acute Retinal manifestations of clinical approach to patient posterior multifocal AIDS, 119 with,31-43 (APMPPE), 236-239 Retinal necrosis, 28 common entities associated PMH (past medical history), 33 Retinal necrosis syndrome, with,l1 Pneumocystis carinii, 165 acute (ARN), 115-117 local, systemic disease Pneumocystosis, 165-166 bilateral (BARN), 115-117 versus, 40 POH (past ocular history), 32- Retinal periphlebitis, 26 location of, 10, 40 33 Retinal pigment epitheliitis, uveitis and, see Ocular Polyarteritis nodosa (PAN), acute (ARPE), 239-240 inflammation and uveitis 213-214 Retinal pigment epithelium Ocular inflammation and Polychondritis, relapsing, 209- (RPE),26 uveitis 211 inflammation of, 28 differential diagnosis, 41-43 Polymyositis, dermatomyositis signs in, 25-29 laboratory evaluation, 47-48 and (DM-PM), 202-203 Retinal surgery,
Load more

Recommended publications
  • Difference Between Hypersensitivity and Autoimmunity Key Difference – Hypersensitivity Vs Autoimmunity
    Difference Between Hypersensitivity and Autoimmunity www.differencebetwee.com Key Difference – Hypersensitivity vs Autoimmunity Autoimmunity is an adaptive immune response mounted against self-antigens. In simple terms, when your body is acting against its own cells and tissues, this is called an autoimmune reaction. An exaggerated and inappropriate immune response to an antigenic stimulus is defined as a hypersensitivity reaction. Unlike autoimmune reactions that are triggered only by the endogenous antigens, hypersensitivity reactions are triggered by both endogenous and exogenous antigens. This is the key difference between hypersensitivity and autoimmunity. What is Hypersensitivity? An exaggerated and inappropriate immune response to an antigenic stimulus is defined as a hypersensitivity reaction. The first exposure to a particular antigen activates the immune system and, antibodies are produced as a result. This is called sensitization. Subsequent exposures to the same antigen give rise to hypersensitivity. Few important facts regarding the hypersensitivity reactions are given below They can be elicited by both exogenous and endogenous agents. They are a result of an imbalance between the effector mechanisms and the countermeasures that are there to control any inappropriate execution of an immune response. The presence of a genetic susceptibility increases the likelihood of hypersensitivity reactions. The manner in which hypersensitivity reactions harm our body is similar to the way that the pathogens are destroyed by immune reactions. Figure 01: Allergy According to the Coombs and Gell classification, there are four main types of hypersensitivity reactions. Type I- Immediate Type/ Anaphylactic Mechanism Vasodilation, edema, and contraction of smooth muscles are the pathological changes that take place during the immediate phase of the reaction.
    [Show full text]
  • Ii Vasclitides
    ا يمون وپات وژنز واسکوليتھااکلتا Vascliiitides: The Immunopa tho genes is دکتر محمدمھدی محمدی LMD, PhD, MPH ([email protected]) The 7th International 12th National Congress on Quality Improvement in Clinical Laboratories 28 Farvardin 1393 / 17April 2014 , Tehran, Iran A small spoonful of Terminology (in Farsi بيماريزايی) – .path·o·gen·e·sis, n • – the ppp(roduction and development of disease (events and reactions and other pathologic mechanisms) . Also, pa·thog·e·ny !?! (in Farsi بيماريزايی) _ .path·o·ge·nic·i·ty, n • – the disease-producing capacity of a pathogen. [PATHOGENIC + -ITY] • vir·u·lence, n. – the relative ability of a microorganism to cause disease; degree of pathogenicity. • Vasculitis, n. (vasculitides, plural) – a general term for vessel wall inflammation, systemic or localized, immune-mediated or directly invaded by microbes. • Infections may indirectly generate vasculitis, e.g. through IC formation or by X_reaction. Note that immunosuppressive therapy is only appropriate for --?– type! • WHAT R the IMMUNE MECHANISMS in VASCULITIS? افراط تعادل تفريط Immunodeficiency Allergy (& Infection) Defence Immunodeficiency Surveillance Autoimmunity (& Malignancy) Homostasis ?! Some Inter-related Concepts Immunological Vasculitis Hypersensitivity Auoimmunity Tolerance EDUCATION? Tolerance in different classic Txtbks of Immunology (Abbas, Benjamini, Janeway, Kuby, Roitt, Stites …) • Tolerance (by C&M Immunology): – Unresponsiveness of the adaptive immune system to antigens, as a result of inactivation or death of antigen-specific lymphocytes, induced by exposure to the antigens. – (()Active) Unresponsiveness of the (()HEALTHY) adappytive immune system to (selected) antigens, as a result of (i.e. MECHANISMS:) inactivation or death of antigen-specific lymphocytes, induced by exposure to those antigens. • Tolerance to self antigens is a normal feature of the adaptive immune system, but tolerance to foreign antigens may be induced undtiditiftider certain conditions of antigen exposure.
    [Show full text]
  • Hypersensitivity Reactions (Types I, II, III, IV)
    Hypersensitivity Reactions (Types I, II, III, IV) April 15, 2009 Inflammatory response - local, eliminates antigen without extensively damaging the host’s tissue. Hypersensitivity - immune & inflammatory responses that are harmful to the host (von Pirquet, 1906) - Type I Produce effector molecules Capable of ingesting foreign Particles Association with parasite infection Modified from Abbas, Lichtman & Pillai, Table 19-1 Type I hypersensitivity response IgE VH V L Cε1 CL Binds to mast cell Normal serum level = 0.0003 mg/ml Binds Fc region of IgE Link Intracellular signal trans. Initiation of degranulation Larche et al. Nat. Rev. Immunol 6:761-771, 2006 Abbas, Lichtman & Pillai,19-8 Factors in the development of allergic diseases • Geographical distribution • Environmental factors - climate, air pollution, socioeconomic status • Genetic risk factors • “Hygiene hypothesis” – Older siblings, day care – Exposure to certain foods, farm animals – Exposure to antibiotics during infancy • Cytokine milieu Adapted from Bach, JF. N Engl J Med 347:911, 2002. Upham & Holt. Curr Opin Allergy Clin Immunol 5:167, 2005 Also: Papadopoulos and Kalobatsou. Curr Op Allergy Clin Immunol 7:91-95, 2007 IgE-mediated diseases in humans • Systemic (anaphylactic shock) •Asthma – Classification by immunopathological phenotype can be used to determine management strategies • Hay fever (allergic rhinitis) • Allergic conjunctivitis • Skin reactions • Food allergies Diseases in Humans (I) • Systemic anaphylaxis - potentially fatal - due to food ingestion (eggs, shellfish,
    [Show full text]
  • Immune Pathology Immune System Functions Reactivity to Tolerance Nonshared Ag to Self-Ag
    Immune Pathology Immune system functions reactivity to tolerance nonshared Ag to self-Ag reduction pErVeRsIoN malfunction immunodeficiency hypersensitivity autoimmune diseases Hypersensitivity Hypersensitivity - excessive or inadequate manifestation adaptive immune of reactions Can manifest as local and systemic reactions Hypersensitivity Type Synonym Immunological mechanisms I IgE-mediated, anaphylactic, IgE-mediated degranulation of mast reaginic, HIS (blood cells dyscrasia) II antibody-dependent Cytotoxic antibodies activate cytotoxicity complement, which leads to cell lysis III immune complex Immune complexes activate leukocytes IV cell-mediated, delayed-type Cytokine production by hypersensitivity macrophages and lymphocytes V antibody-dependent Antibodies alter functional state of functional changes cells by interacting with its receptor Type I hypersensitivity • Speed ​​of reaction - seconds or minutes • IgE-mediated • Chemical mediators of damage - vasoactive products of mast cells / basophils (histamine, arachidonic acid derivatives) • Mechanism - accumulation of of neutrophils, unstriated muscle spasm Type I hypersensitivity • bronchial asthma (some forms) • anaphylactic shock • Urticaria • Quincke's edema • dietary allergy • nasal allergy • allergic conjunctivitis Mast cell Аг Synthesis and secretion: leukotrienes (LTC4, LTB4), prostaglandins (PGD2), degranulation: IL-3, 4,5,6 histamine Platelet-activating factor serotonin (PAF) eotoxin Type I hypersensitivity Morphological manifestations IHS: • exudative alterative inflammation
    [Show full text]
  • Hypersensitivity Reactions
    Color code: Important in red Extra in blue Hypersensitivity Reactions For team error adjustments, click here Objectives ➤ To know that hypersensitivity reactions are over and excessive immune responses that can be harmful to the body in four different ways ➤ To be familiar with inflammatory processes in Type I hypersensitivity reaction that mediate allergic inflammation ➤ To recognize that Type II hypersensitivity deals with immune responses against antigens that are integral parts of the cell membrane and are usually associated with autoimmune disorders ➤ To know that Type III hypersensitivity reactions are mediated by immune complexes and cause vasculitis ➤ To describe Type IV hypersensitivity is a purely cell mediated immune response associated with chronic inflammation What is hypersensitivity? Hypersensitivity: is an undesirable Protective immunity: desirable reaction by the immune system. reaction. Gell—Coombs Classification of Hypersensitivity Reactions Type I: Type IV: IgE mediated Type II: Type III: IgG mediated IgG mediated T cell (most (destruction (immune mediated allergic of cells) complex) immunity reactions) Type I Hypersensitivity ● Known as immediate hypersensitivity (mins-hrs) or an allergic reaction that may develop into an anaphylactic* reaction (a severe and life-threatening form). Antibody - Allergic (atopic): IgE - Non Allergic: IgG Features Cells Involved - Mast cells - Eosinophils - Basophils Antigen - Allergen (low molecular weight & high solubility) Ex: Pollens, Dust mites, Injected allergen (sting venom from
    [Show full text]
  • Hypersensitive Reactions
    Hypersensitive reactions For B.Sc Life Sciences VI Sem Paper Immunology Teacher: Dr. Renu Solanki There Are Several Components of Type I Reactions 1. Allergens: The majority of humans mount significant IgE responses only as a defense against parasitic infections. After an individual has been exposed to a parasite, serum IgE levels increase and remain high until the parasite is successfully cleared from the body. The term allergen refers specifically to nonparasitic antigens capable of stimulating type I hypersensitive responses in allergic individuals. 2. REAGINIC ANTIBODY (IGE): Serum IgE levels in normal individuals fall within the range of 0.1–0.4 µg/ml; even the most severely allergic individuals rarely have IgE levels greater than 1 µg/ml. IgE was found to be composed of two heavy and two light chains with a combined molecular weight of190,000.The higher molecular weight as compared with IgG (150,000) is due to the presence of an additional constant-region domain (see Figure 4- 13). This additional domain (C H 4) contributes to an altered conformation of the Fc portion of the molecule that enables it to bind to glycoprotein receptors on the surface of basophils and mast cells. Although the half-life of IgE in the serum is only 2–3 days, once IgE has been bound to its receptor on mast cells and basophils,it is stable in that state for a number of weeks. IgE Crosslinkage Initiates Degranulation Type I Reactions Can Be Systemic or Localized SYSTEMIC ANAPHYLAXIS LOCALIZED ANAPHYLAXIS (ATOPY) -ALLERGIC RHINITIS: ALLERGIC RHINITIS: Results from the reaction of airborne allergens with sensitized mast cells in the conjunctivae and nasal mucosa to induce the release of pharmacologically active mediators from mast cells; these mediators then cause localized vasodilation and increased capillary perme- ability.
    [Show full text]
  • Biochemistry Hypersensitivity IV and V
    Description of Module Paper : 16 Immunology Module : 30 Hypersensitivity IV and V Principal Investigator Dr. Sunil Kumar Khare,Professor Dept. of Chemistry, I.I.T. Delhi Paper Coordinator Dr. M.N.Gupta, Emeritus Professor and Dept. of Biochemical Engg. and Content Writer Biotechnology, I.I.T. Delhi Content Reviewer: Dr. Prashant Mishra, Professor Dept. of Biochemical Engg. and Biotechnology, I.I.T. Delhi 1 Immunology Biochemistry Hypersensitivity IV and V Subject Name Biochemstry Paper Name 16 Immunology Module Name/Title 30 Hypersensitivity IV and V Dr. Vijaya Khader Dr. MC Varadaraj 2 Immunology Biochemistry Hypersensitivity IV and V 1. Objectives To understand the three types of class IV hypersensitivity reaction: contact dermatitis, tuberculin reaction and granulomatous hypersensitivity reaction. To explain how machanistically all the three types follow the same route. To learn how certain diseases caused by infectious agent have involvement of type IV hypersensitivity To understand type V hypersensitivity reactions which occur because of chronic stimulation 2. Concept map 3 Immunology Biochemistry Hypersensitivity IV and V Type IV hypersensitivity is also called delayed type as results are seen from 48 hrs-28 days ! In the three variants of type IV, the delay is of different time periods. We will also look at the type V hypersensitivity which was introduced as a separate class after Coombs and Geller classification. This hypersensitivity is involved in some autoimmune diseases. Contact with some substances can cause contact dermatitis. Injection of some antigens derived from infectious agents can be used as a test for hypersensitivity towards that microbe. When some microbes persist, it causes formation of granulomes.
    [Show full text]
  • Hypersensitivity Reaction Types
    put together by Alex Yartsev: Sorry if i used your images or data and forgot to reference you. Tell me who you are. [email protected] ypersensitivity Reactions ripped shamelessly fffrfrrromom a website which can no longer be recalled Type I - immediate hypersensitivity Mediated by IgE antibodies and produced by the immediate release of histamine, arachidonate and derivatives by basophils and mast cells. This causes an inflammatory response leading to an immediate (within seconds to minutes) reaction. Some examples: • Allergic asthma • Allergic conjunctivitis • Allergic rhinitis ("hay fever") • Anaphylaxis • Angioedema • Urticaria (hives) Type II - antibody-dependent hypersensitivity In type II hypersensitivity, the antibodies produced by the immune response bind to antigens on the patient's own cell surfaces. IgG and IgM antibodies bind to these antigens to form complexes that activate the classical pathway of complement activation for eliminating cells presenting foreign antigens (which are usually, but not in this case, pathogens). That is, mediators of acute inflammation are generated at the site and membrane attack complexes cause cell lysis and death. The reaction takes hours to a day. Some examples: • Autoimmune haemolytic anaemia • Goodpasture's syndrome • Pemphigus • Pernicious anemia • Immune thrombocytopenia • Transfusion reactions Type III - immune complex hypersensitivity In type III hypersensitivity, soluble immune complexes (aggregations of antigens and IgG and IgM antibodies) form in the blood and are deposited
    [Show full text]
  • Immune-Mediated Diseases in a Nutshell
    Immune-Mediated Diseases In a Nutshell Objectives Describe the epidemiology, clinical presentation, pathogenesis and pathologic changes of autoimmune diseases, including lupus erythematosis, rheumatoid arthritis, vasculitis, temporal arteritis and Wegener's granulomatosis Systemic Lupus Erythematosus Systemic lupus erythematosus: clinical features Febrile, multisystem inflammatory disease Variably affects wide range of organs and tissues, especially skin, kidneys, serosal surfaces, joints, heart Clinical course highly variable, often with multiple exacerbations and remissions Especially prevalent in young women, black Americans Prevalence: up to 1 to 2,500 persons Systemic lupus erythematosus: pathogenesis Autoantibodies develop against a variety of antigens: Nucleoproteins / nucleic acids DNA histones nonhistone RNA-binding proteins Blood cells erythrocytes platelets lymphocytes Phospholipids (e.g., “lupus anticoagulant”) Systemic lupus erythematosus: pathogenesis Antigen-antibody Antibody bound to immune complexes cells leads to lysis form via complement- mediated Complexes deposit in cytotoxicity or numerous sites, ADCC initiate complement cascade, and trigger inflammation Type III Hypersensitivity Type II Hypersensitivity Systemic lupus erythematosus: pathogenesis Possible causes of autoantibody production Intrinsic B cell defect Excessive helper T cell activity Deficient suppressor T cell activity Rheumatoid Arthritis Rheumatoid arthritis: clinical features Systemic, chronic inflammatory disease Principally affects joints: severe,
    [Show full text]
  • Hypersensitivity Mechanisms: an Overview
    Hypersensitivity Mechanisms: An Overview Stephen Canfield, MD, PhD Asst. Prof. Medicine Pulmonary, Allergy, and Critical Care Medicine 1 Origins of Hypersensitivity “Hypersensitivity” first used clinically in 1893: • attempting to protect against diphtheria toxin • test animals suffered enhanced responses, even death following second toxin exposure Emil von • at miniscule doses not harmful to untreated Behring animals The term “Allergy” is coined in 1906: • postulated to be the product of an “allergic” response • from Greek allos ergos (altered reactivity) Clemens von Pirquet os from Silverstein, AM. 1989. A History of Immunology. Academic Press, San Diego 2 First Task of the Immune System Dangerous Innocuou ? s? 3 Modern Use • Hypersensitivity: • Aberrant or excessive immune response to foreign antigens • Primary mediator is the adaptive immune system • T & B lymphocytes • Damage is mediated by the same attack mechanisms that mediate normal immune responses to pathogen 4 Mechanisms of Hypersensitivity Gell & Coombs Classification G&C Common Term Mediator Example Class Type I Immediate Type IgE monomers Anaphylaxis IgG/IgM Drug-induced Type II Cytotoxic Type monomers hemolysis Immune Complex IgG/IgM Type III Serum sickness Type multimers PPD rxn Type IV Delayed Type T cells Contact Dermatitis 5 Common to All Types Adaptive (T & B Cell) Immune Responses • Reactions occur only in sensitized individuals • Generally at least one prior contact with the offending agent • Sensitization can be long lived in the absence of re-exposure (>10 years)
    [Show full text]
  • Diseases of the Immune System 813
    Chapter 19 | Diseases of the Immune System 813 Chapter 19 Diseases of the Immune System Figure 19.1 Bee stings and other allergens can cause life-threatening, systemic allergic reactions. Sensitive individuals may need to carry an epinephrine auto-injector (e.g., EpiPen) in case of a sting. A bee-sting allergy is an example of an immune response that is harmful to the host rather than protective; epinephrine counteracts the severe drop in blood pressure that can result from the immune response. (credit right: modification of work by Carol Bleistine) Chapter Outline 19.1 Hypersensitivities 19.2 Autoimmune Disorders 19.3 Organ Transplantation and Rejection 19.4 Immunodeficiency 19.5 Cancer Immunobiology and Immunotherapy Introduction An allergic reaction is an immune response to a type of antigen called an allergen. Allergens can be found in many different items, from peanuts and insect stings to latex and some drugs. Unlike other kinds of antigens, allergens are not necessarily associated with pathogenic microbes, and many allergens provoke no immune response at all in most people. Allergic responses vary in severity. Some are mild and localized, like hay fever or hives, but others can result in systemic, life-threatening reactions. Anaphylaxis, for example, is a rapidly developing allergic reaction that can cause a dangerous drop in blood pressure and severe swelling of the throat that may close off the airway. Allergies are just one example of how the immune system—the system normally responsible for preventing disease—can actually cause or mediate disease symptoms. In this chapter, we will further explore allergies and other disorders of the immune system, including hypersensitivity reactions, autoimmune diseases, transplant rejection, and diseases associated with immunodeficiency.
    [Show full text]
  • 1. Hypersensitivity What Is Hypersensitivity?
    Chapter 19: Disorders of the Immune System 1. Hypersensitivity 2. Autoimmunity 3. Transplant Rejection 1. Hypersensitivity What is Hypersensitivity? Hypersensitivity is an immunological state in which the immune system “over-reacts” to foreign antigen such that the immune response itself is more harmful than the antigen. All types of hypersensitivity involve: • the adaptive immune response • i.e., highly specific reactions via T or B cells • prior exposure to the antigen • the initial exposure sensitizes the individual but does NOT cause a hypersensitive reaction • hypersensitivity is only seen on secondary exposure 1 Types of Hypersensitivity Hypersensitivity following secondary exposure to antigen comes in 4 basic forms: *Type I: allergic reactions (“immediate” hypersensitivity) • IgE mediated and very rapid (2-30 minutes) *Type II: cytotoxic reactions • cell damage due to complement activation via IgM or IgG *Type III: immune complex reactions • cell damage due to excess antibody/antigen complexes Type IV: delayed cell-mediated reactions • cell damage involving T cells & macrophages * Types I-III are all antibody-mediated, Type IV is not! Type I: Allergic Reactions Allergic (anaphylactic) reactions involve the activation of mast cells or basophils through the binding of antigen to IgE on the cell surface: • mast cells & basophils have IgE receptors that bind the constant region of any IgE antibody • “cross-linking” of IgE molecules on the cell surface by binding to antigen triggers the release of “mediators” • mediators = histamine, prostaglandins & leukotrienes …more on Allergic Reactions The release of these mediators causes the redness, swelling, itching, mucus, etc, that characterize allergic reactions: Most allergic reactions are local: • itching, redness, hives in the skin, mucus, sneezing • usually due to inhaled or ingested antigens Systemic allergic reactions can be lethal: • severe loss of blood pressure, breathing difficulty (anaphylactic shock) • usu.
    [Show full text]